Town Lane Raises $1.25 Billion for Inaugural Real Estate Investment Fund
U.S. Focused Fund to Invest Opportunistically Across Asset Classes NEW YORK–(BUSINESS WIRE)–Town Lane (“Town Lane” or the “Firm”), an opportunistic... Read more.
SAIC Board of Directors Declares Cash Dividend
RESTON, Va.–(BUSINESS WIRE)–Science Applications International Corp. (Nasdaq: SAIC) announced today that the company’s board of directors declared... Read more.
SAIC Board of Directors Declares Cash Dividend
RESTON, Va.–(BUSINESS WIRE)–Science Applications International Corp. (Nasdaq: SAIC) announced today that the company’s board of directors declared... Read more.
EVOKE-01 Study Results in Metastatic NSCLC to Be Presented at an Oral Session at ASCO 2024
– Simultaneously Published by the Journal of Clinical Oncology – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced... Read more.
Masimo Announces Nomination of Independent Candidate to the Board of Directors
Experienced Medical Device Executive Christopher Chavez to Stand for Election at 2024 Annual Meeting Company Extends Third Settlement Offer to Politan; Politan... Read more.
Guardant Health Named to TIME100 Most Influential Companies
Guardant’s Impact, Innovation, Ambition, and Success Contributed to the Recognition PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (NASDAQ:GH),... Read more.
Everspin Technologies Announces Updated Presentation Time at the Maxim Virtual TMT Conference
CHANDLER, Ariz.–(BUSINESS WIRE)–Everspin Technologies, Inc. (NASDAQ: MRAM), the world’s leading developer and manufacturer of magnetoresistive random... Read more.
Western Asset Inflation-Linked Income Fund (WIA or “the Fund”; CUSIP: 95766Q106) Announces Notification of Sources of Distributions
NEW YORK–(BUSINESS WIRE)–Western Asset Inflation-Linked Income Fund Notification of Sources of Distributions Pursuant to Section 19(a) of the Investment... Read more.
CVC Credit prices $500m Apidos XLVIII
NEW YORK–(BUSINESS WIRE)–CVC Credit, the $43bn global credit management business of CVC, is pleased to announce that it has successfully priced Apidos... Read more.
Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
An unprecedented 60% of patients remain alive without disease progression after five years Updated results show continued 81% reduction in risk of progression or... Read more.